Actively Recruiting
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Led by University of Miami · Updated on 2026-02-20
400
Participants Needed
3
Research Sites
90 weeks
Total Duration
On this page
Sponsors
U
University of Miami
Lead Sponsor
B
Blood Cancer United
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.
CONDITIONS
Official Title
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with or have a recurrence of leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
- Received, are receiving, or plan to receive primary or relapse treatment for blood cancer
- Currently receiving treatment started within the past 18 months, or planning to start treatment within one month, or have received Bone Marrow Transplant or CAR-T cell therapy within the past 100 days
- Not currently participating in any Blood Cancer United programs or services
- Willing to be followed for 6 months
- Speak English or Spanish
You will not qualify if you...
- Not diagnosed with leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myeloproliferative neoplasms (MPN)
- Do not meet treatment criteria (not currently receiving treatment started within past 18 months, not planning to start treatment within one month, and no Bone Marrow Transplant or CAR-T cell therapy within past 100 days)
- Currently participating in any Blood Cancer United programs or services
- Not willing to be followed for 6 months
- Do not speak English or Spanish
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Sylvester Comprehensive Cancer Center
Miami, Florida, United States, 33136
Actively Recruiting
2
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States, 60637
Not Yet Recruiting
3
Mays Cancer Center at UT Health San Antonio
San Antonio, Texas, United States, 78229
Not Yet Recruiting
Research Team
C
Carlos Melara, MD
CONTACT
S
Sara Fleszar-Pavlovic, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here